The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Abatacept for immune checkpoint inhibitor associated myocarditis (ATRIUM): Phase 3, investigator-initiated, randomized, placebo-controlled study to evaluate the efficacy and safety of abatacept compared to placebo in hospitalized patients with immune checkpoint inhibitor associated myocarditis.
 
Kerry Lynn Reynolds
Employment - Project Data Sphere; Teladoc
Stock and Other Ownership Interests - Biogen (I)
Honoraria - CME Outfitters; MedScape
Consulting or Advisory Role - SAGA Diagnostics
Other Relationship - Project Data Sphere
 
Daniel A. Zlotoff
Consulting or Advisory Role - Bristol-Myers Squibb; Freeline Therapeutics; Intrinsic Imaging; Intrinsic Imaging
 
Meghan Mooradian
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Istari Oncology; Xilio Therapeutics
Other Relationship - Aptitude Health; Curio Science; OncLive/MJH Life Sciences
 
Leyre Zubiri
Consulting or Advisory Role - Merck
 
Paul Ridker
Stock and Other Ownership Interests - Angiowave; Uppton
Consulting or Advisory Role - Agepha Pharma; AstraZeneca; Baim Institute for Clinical Research; Cardiol Therapeutics; CiVi Biopharma; Flame, Inc; Health Outlook; Horizon Pharma; IQVIA; Leducq Foundation; Montai Health; NewAmsterdam Pharma; Novo Nordisk; Pfizer; SOCAR; TenSixteen Bio; University of Toronto; Zomagen Biosciences
Research Funding - Amarin Corporation; Bristol Myers Squibb Foundation; Kowa Pharmaceutical; National Heart, Lung, and Blood Institute; Novartis
 
Tomas G. Neilan
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; C4 Therapeutics; CRC Oncology; Intrinsic Imaging; Parexel; Roche/Genentech; Sanofi
Research Funding - AstraZeneca; Bristol Myers Squibb Foundation